SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001437749-22-003169
Filing Date
2022-02-14
Accepted
2022-02-11 21:48:51
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM S-1 navb20220211_s1.htm S-1 955144
2 EXHIBIT 23.1 ex_335073.htm EX-23.1 3004
3 EXHIBIT FILING FEES ex_335141.htm EX-FILING FEES 15887
4 navb20220211_s1img001.jpg GRAPHIC 2924
  Complete submission text file 0001437749-22-003169.txt   979295
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-262691 | Film No.: 22624343
SIC: 2835 In Vitro & In Vivo Diagnostic Substances